Free Trial

Salesforce (CRM) Stock Forecast & Price Target

Salesforce logo
$342.02 +6.24 (+1.86%)
(As of 11/22/2024 ET)

Salesforce - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
31

Based on 39 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 39 analysts, 8 have given a hold rating, 27 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$336.37
-1.65% Downside
According to the 39 analysts' twelve-month price targets for Salesforce, the average price target is $336.37. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted downside of -1.65% from the current price of $342.02.
Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

Sign Up

CRM Analyst Ratings Over Time

TypeCurrent Forecast
11/26/23 to 11/25/24
1 Month Ago
10/27/23 to 10/26/24
3 Months Ago
8/28/23 to 8/27/24
1 Year Ago
11/26/22 to 11/26/23
Strong Buy
4 Strong Buy rating(s)
4 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
27 Buy rating(s)
25 Buy rating(s)
24 Buy rating(s)
25 Buy rating(s)
Hold
8 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
13 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$336.37$312.51$292.38$243.39
Forecasted Upside-1.65% Downside7.59% Upside10.63% Upside8.47% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Salesforce Stock vs. The Competition

TypeSalesforceComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.90
2.68
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-1.65% Downside532.55% Upside7.66% Upside
News Sentiment Rating
Positive News

See Recent CRM News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/22/2024UBS Group
4 of 5 stars
 Boost TargetNeutral ➝ Neutral$275.00 ➝ $360.00+5.26%
11/22/2024JMP Securities
2 of 5 stars
 Boost TargetMarket Outperform ➝ Market Outperform$342.00 ➝ $450.00+33.85%
11/21/2024TD Cowen
4 of 5 stars
 Boost TargetHold ➝ Hold$290.00 ➝ $340.00+0.01%
11/21/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$330.00 ➝ $385.00+16.49%
11/20/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$310.00 ➝ $340.00+5.17%
11/19/2024Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
11/18/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$425.00+31.89%
11/15/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$305.00 ➝ $385.00+16.12%
11/14/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$270.00 ➝ $340.00+1.92%
11/13/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$325.00 ➝ $390.00+13.03%
11/12/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$275.00 ➝ $330.00-4.35%
11/11/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$350.00 ➝ $400.00+22.40%
10/28/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$320.00 ➝ $350.00+18.41%
10/17/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aaron Siegel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$343.00+16.88%
10/10/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
10/2/2024Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
10/2/2024Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$270.00 ➝ $400.00+47.67%
9/27/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$315.00 ➝ $325.00+17.67%
9/20/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$345.00 ➝ $345.00+29.76%
9/19/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$300.00 ➝ $315.00+17.01%
9/19/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+15.14%
8/30/2024Phillip Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Accumulate$305.00+20.72%
8/29/2024FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seyrafi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$234.00 ➝ $236.00-8.87%
8/29/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$335.00 ➝ $335.00+28.58%
8/29/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$230.00 ➝ $250.00-2.93%
8/29/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$300.00 ➝ $315.00+22.31%
8/29/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$320.00 ➝ $330.00+27.46%
8/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$325.00 ➝ $350.00+35.19%
8/29/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$295.00 ➝ $315.00+21.63%
8/26/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$260.00 ➝ $290.00+8.59%
8/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+13.39%
5/31/2024Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$330.00 ➝ $275.00+20.09%
5/30/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$355.00 ➝ $305.00+40.88%
5/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$350.00 ➝ $300.00+39.82%
5/30/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$345.00 ➝ $300.00+10.25%
4/16/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$365.00+33.82%
3/21/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Weight
3/6/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$290.00 ➝ $354.00+16.46%
Automatic Income (from home) (Ad)

Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…

10/2/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeConviction-Buy ➝ Buy
9/15/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$267.00+22.04%
6/1/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Baldry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
6/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
3/2/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$140.00 ➝ $200.00+19.51%
2/21/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$160.00 ➝ $170.00+2.92%
1/20/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
12/5/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$250.00 ➝ $225.00+55.64%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:56 AM ET.


Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 6, 2024. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

  • Salesforce's consistent dividend payouts provide a steady income stream for investors, with a current dividend yield of 0.56%.
  • Analysts have given Salesforce a positive outlook, with a majority of them rating the stock as a buy or strong buy, indicating confidence in the company's future performance.
  • Institutional investors, such as Vanguard Group Inc. and Capital Research Global Investors, have been increasing their stakes in Salesforce, signaling strong confidence in the company's growth potential.
  • Recent insider activity, including significant share sales by directors, may indicate that insiders believe the stock is currently overvalued, potentially prompting a correction in the stock price.
  • Despite a slight decrease in stock price on the trading day, Salesforce's overall performance has been positive, with the stock trading at $288.10, showing resilience in the market.

Salesforce
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

  • The company's payout ratio of 28.78% indicates that a significant portion of its earnings is being distributed as dividends, potentially limiting funds available for reinvestment in growth initiatives.
  • While the majority of analysts have a positive outlook on Salesforce, there are still some hold ratings, suggesting a level of uncertainty or caution among a portion of analysts regarding the company's future performance.
  • Insider selling activity, with directors selling significant amounts of shares, may raise concerns about insider confidence in the company's long-term prospects.
  • Despite institutional investors increasing their stakes, the high percentage of institutional ownership at 80.43% may lead to increased volatility in the stock price due to large-scale buying or selling decisions by these entities.
  • Recent fluctuations in the stock price, including a decrease on the trading day, could indicate short-term market uncertainty or potential volatility in the near future.

CRM Forecast - Frequently Asked Questions

According to the research reports of 39 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $336.37, with a high forecast of $450.00 and a low forecast of $236.00.

39 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 8 hold ratings, 27 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted downside of -1.65% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 6 upgrades and 1 downgrade by analysts.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.90 while the average consensus rating score for "computer and technology" companies is 2.67. Learn more on how CRM compares to other companies.


This page (NYSE:CRM) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners